Explore our materials

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Debate: HIV is no special population anymore - Sanjay Bhagani, BSc, FRCP

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Recreational drug use in the HIV population - David Stuart

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

26_Dieterich

Vincent Soriano

MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Delta Hepatitis-New approaches to therapy - Vincent Soriano, MD, PhD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Viral Hepatitis and Malignancy - David Pinato, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

HBV - Current and Future Treatment paradigms - Patrick Kennedy, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

NASH, what is it, who gets it and what are the implication for the HIV patient - Emmanouil Tsochatzis, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Immunology and the pathophysiology of liver disease in coinfection - Raymond Chung, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

ESLD and its complications - Massimo Puoti, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Management of HCV: Pre and Post transplant - Kosh Agarwal, MD

Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015

Towards more affordable HCV therapy - Andrew Hill, MD